301234.CS▼
Wuzhou Medical Releases 2026 Interim Report with Net Profit of 15.3634 Million Yuan
Wuzhou Medical released its 2026 interim report, with net profit attributable to the parent company of 15.3634 million yuan. The company's total operating revenue was 203 million yuan, down 6.40% from the same period last year. Net cash inflow from operating activities was 28.479 million yuan, down 43.05% year-on-year. The company's latest asset-liability ratio was 10.82%, gross margin was 18.08%, ROE was 2.01%, and diluted earnings per share was 0.23 yuan.